NIR-II nanoprobes in-vivo assembly to improve image-guided surgery for metastatic ovarian cancer
2018 · Nature Communications · 436 citations
https://doi.org/10.1038/s41467-018-05113-8
C
Congjian Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
224
Papers
6.3K
Citations
40
h-index
117
i10-index
Congjian Xu is an academic researcher from Shanghai Medical College of Fudan University. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometriosis Research and Treatment & Gut microbiota and health. The author has an h-index of 40, co-authored 191 publications.
ORCID: 0000-0002-7954-5892Papers by this author
worksCXCL13 shapes immunoactive tumor microenvironment and enhances the efficacy of PD-1 checkpoint blockade in high-grade serous ovarian cancer
2021 · Journal for ImmunoTherapy of Cancer · 219 citations
https://doi.org/10.1136/jitc-2020-001136
Tumour-associated neutrophils orchestrate intratumoural IL-8-driven immune evasion through Jagged2 activation in ovarian cancer
2020 · British Journal of Cancer · 70 citations
https://doi.org/10.1038/s41416-020-1026-0
E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway
2017 · Scientific Reports · 69 citations
https://doi.org/10.1038/srep44744
The molecular regulatory mechanisms of meiotic arrest and resumption in Oocyte development and maturation
2023 · Reproductive Biology and Endocrinology · 51 citations
https://doi.org/10.1186/s12958-023-01143-0
Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor
2018 · BMC Cancer · 32 citations
https://doi.org/10.1186/s12885-018-4918-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat